NextCell Pharma Stock

NextCell Pharma OCF Margin

The Operating Cash Flow Margin of NextCell Pharma (NXTCL.ST) as of Jul 27, 2026 is -355.34 %. In the previous year, Operating Cash Flow Margin was -354.24 % — a change of 0.31% (lower).

OCF Margin

-355.34 %

YoY

0.31%

Last updated:

Operating Cash Flow Margin of NextCell Pharma is 2026 -355.34 % . Operating Cash Flow Margin of NextCell Pharma was 2025 -354.24 % . It decreases by 0.31% lower compared to the previous year.
Access this data via the Eulerpool API

NextCell Pharma Stock analysis

What does NextCell Pharma do? NextCell Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NextCell Pharma stock

Operating Cash Flow Margin of NextCell Pharma is -355.34 % in 2026.

Access this data via the Eulerpool API

Margins — NextCell Pharma

All Key Metrics — NextCell Pharma